Our approach includes: Comprehensive screening before prescribing Mounjaro Regular check-ins with our healthcare team Education about warning signs and when to seek help Support from registered dietitians who understand medication side effects Guidance on nutrition that supports pancreatic health Weve worked with the NHS for over 6 years and built our medication programme with scientific evidence, patient safety, and data security at its core
Federal law places clear limits on compounding
We do not recommend the use of Semaglutide for people with the following conditions: Semaglutide allergy Endocrine neoplasia A personal or family history of medullary thyroid carcinoma A diabetic ketoacidosis A stomach or intestinal disorder Pancreatitis Kidney disease Retinopathy For further details: Click here Request Appointment Semaglutide Weight Loss Therapy Clinic Near Denton, TX What is Semaglutide
While the recent phase 3 trial for orforglipron was specifically for type 2 diabetes and not weight loss, the study found that patients who took the drug lost considerable weight
Eli Lilly and Company reported that its investigational oral GLP-1 receptor agonist, orforglipron, achieved superior oral GLP-1 receptor agonist performance in type 2 diabetes management compared with oral semaglutide in a head-to-head phase 3 trial Furthermore, RPG Life Sciences is sharpening its strategy today with a strong focus on its GLP-1 entry plan and expanding API business, signaling a shift toward high-growth pharmaceutical segments
#PeptideTherapy #HormoneOptimization #ProAgeWellness #FDACompounding #EllieMD To view or add a comment, sign in FDA just released new peptide compounding documents, and the headlines are already getting ahead of the facts